Supplemental material
Human Vaccines & Immunotherapeutics
Volume 17, 2021 - Issue 11
Short Report
Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy
Paolo Bonannia Department of Health Sciences, University of Florence, Italy
https://orcid.org/0000-0003-2875-3744View further author information
https://orcid.org/0000-0003-2875-3744View further author information, , Elisabetta Francoc Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italyhttps://orcid.org/0000-0002-1179-4411View further author information
https://orcid.org/0000-0002-1179-4411View further author information, Giovanni Gabuttid Department of Medical Sciences, University of Ferrara, Ferrara, Italyhttps://orcid.org/0000-0002-7259-4923View further author information
https://orcid.org/0000-0002-7259-4923View further author information, Federico Marchettie GSK, Verona, ItalyCorrespondence[email protected]
https://orcid.org/0000-0001-6435-8990View further author information
https://orcid.org/0000-0001-6435-8990View further author information, Antonella Matteif Department of Life, Health & Environmental Sciences, University of L’Aquila, L’Aquila, Italyhttps://orcid.org/0000-0001-6420-8116View further author information
https://orcid.org/0000-0001-6420-8116View further author information, Rosa Pratog Department of Medical and Surgical Sciences, University of Foggia; Department of Hygiene, Policlinico Riuniti University Hospital of Foggia, Foggia, Italyhttps://orcid.org/0000-0001-8138-5835View further author information
https://orcid.org/0000-0001-8138-5835View further author information, & Francesco Vitalei Department of Health Promotion, Maternal-Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italyhttps://orcid.org/0000-0002-6354-8060View further author information
https://orcid.org/0000-0002-6354-8060View further author information show all